Abstract
Treatment of infected patients with ABT-538, an inhibitor of the protease of human immuno-deficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 ±0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.
Original language | English |
---|---|
Pages (from-to) | 123-126 |
Number of pages | 4 |
Journal | Nature |
Volume | 373 |
Issue number | 6510 |
DOIs | |
State | Published - 12 Jan 1995 |
Externally published | Yes |